Quebec medtech funding program
Appears in 1 story · Last updated Nov 11, 2026
Awarded $700,000 for real-world clinical validation
AI4Eyes completed U.S. Food and Drug Administration establishment registration and device listing for its eye care platform on November 11, 2026. The Montréal company can now sell the system in the United States as a Class I device exempt from 510(k) premarket review.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
